German national surveillance data analysis shows that hospitalisation odds associated with Omicron lineage BA.1 or BA.2 infections are up to 80% lower than with Delta infection, primarily in ≥ 35-year-olds. Hospitalised vaccinated Omicron cases’ proportions (2.3% for both lineages) seemed lower than those of the unvaccinated (4.4% for both lineages). Independent of vaccination status, the hospitalisation frequency among cases with Delta seemed nearly threefold higher (8.3%) than with Omicron (3.0% for both lineages), suggesting that Omicron inherently causes less severe disease.Peer Reviewe
To assess differences in the risk of hospitalisation between the Omicron variant of concern (1) and ...
We aim to compare the severity of infections between omicron and delta variants in 609,352 SARS-CoV-...
This retrospective multi-center matched cohort study assessed the risk for severe COVID-19 (combinat...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (B.1.1.529) rapidly...
We included 39,524 COVID-19 Omicron and 51,481 Delta cases reported in Norway from December 2021 to ...
The Omicron variant of SARS-CoV-2 became the globally dominant variant in early 2022. A sub-lineage ...
Genetic variants of severe acute respiratory syndrome coronavirus (SARS-CoV-2) have been globally su...
Background The Omicron (lineage B.1.1.529) variant of severe acute respiratory syndrome coronavirus...
This retrospective multi-center matched cohort study assessed the risk for severe COVID-19 (combinat...
This retrospective multi-center matched cohort study assessed the risk for severe COVID-19 (combinat...
BackgroundIn summer 2022, SARS-CoV-2 Omicron BA.5 became dominant in Europe. In vitro studies have s...
BACKGROUND: The SARS-CoV-2 Omicron variant became a global concern due to its rapid spread and displ...
BACKGROUND Rapid transmission of the SARS-CoV-2 Omicron variant has led to record-breaking incidence...
BACKGROUND: There is an urgent public health need to evaluate disease severity in adults hospitalise...
BACKGROUND: The SARS-CoV-2 variant of concern, omicron, appears to be less severe than delta. We aim...
To assess differences in the risk of hospitalisation between the Omicron variant of concern (1) and ...
We aim to compare the severity of infections between omicron and delta variants in 609,352 SARS-CoV-...
This retrospective multi-center matched cohort study assessed the risk for severe COVID-19 (combinat...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (B.1.1.529) rapidly...
We included 39,524 COVID-19 Omicron and 51,481 Delta cases reported in Norway from December 2021 to ...
The Omicron variant of SARS-CoV-2 became the globally dominant variant in early 2022. A sub-lineage ...
Genetic variants of severe acute respiratory syndrome coronavirus (SARS-CoV-2) have been globally su...
Background The Omicron (lineage B.1.1.529) variant of severe acute respiratory syndrome coronavirus...
This retrospective multi-center matched cohort study assessed the risk for severe COVID-19 (combinat...
This retrospective multi-center matched cohort study assessed the risk for severe COVID-19 (combinat...
BackgroundIn summer 2022, SARS-CoV-2 Omicron BA.5 became dominant in Europe. In vitro studies have s...
BACKGROUND: The SARS-CoV-2 Omicron variant became a global concern due to its rapid spread and displ...
BACKGROUND Rapid transmission of the SARS-CoV-2 Omicron variant has led to record-breaking incidence...
BACKGROUND: There is an urgent public health need to evaluate disease severity in adults hospitalise...
BACKGROUND: The SARS-CoV-2 variant of concern, omicron, appears to be less severe than delta. We aim...
To assess differences in the risk of hospitalisation between the Omicron variant of concern (1) and ...
We aim to compare the severity of infections between omicron and delta variants in 609,352 SARS-CoV-...
This retrospective multi-center matched cohort study assessed the risk for severe COVID-19 (combinat...